loading

Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie

pulisher
May 29, 2025

Trading (ALDX) With Integrated Risk Controls - news.stocktradersdaily.com

May 29, 2025
pulisher
May 29, 2025

Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference | ALDX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference - Business Wire

May 29, 2025
pulisher
May 26, 2025

Northern Trust Corp Purchases 16,894 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 26, 2025
pulisher
May 25, 2025

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Shares Acquired by Deutsche Bank AG - Defense World

May 25, 2025
pulisher
May 24, 2025

D. E. Shaw & Co. Inc. Sells 146,198 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 24, 2025
pulisher
May 23, 2025

Q3 Earnings Forecast for ALDX Issued By Leerink Partnrs - Defense World

May 23, 2025
pulisher
May 22, 2025

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX): When Will It Breakeven? - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

HC Wainwright Has Strong Forecast for ALDX FY2029 Earnings - Defense World

May 22, 2025
pulisher
May 22, 2025

Q2 EPS Estimate for Aldeyra Therapeutics Lifted by Analyst - Defense World

May 22, 2025
pulisher
May 21, 2025

Aldeyra Therapeutics (NASDAQ:ALDX) Raised to “Sell” at StockNews.com - Defense World

May 21, 2025
pulisher
May 20, 2025

Balyasny Asset Management L.P. Acquires New Stake in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 20, 2025
pulisher
May 20, 2025

Aldeyra Therapeutics (NASDAQ:ALDX) Given “Buy” Rating at HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

ALDX: HC Wainwright & Co. Reiterates Buy Rating with $10 Target | ALDX Stock News - GuruFocus

May 19, 2025
pulisher
May 18, 2025

(ALDX) Trading Report - news.stocktradersdaily.com

May 18, 2025
pulisher
May 18, 2025

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc.ALDX - FinancialContent

May 18, 2025
pulisher
May 18, 2025

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stock Holdings Lessened by Price T Rowe Associates Inc. MD - Defense World

May 18, 2025
pulisher
May 14, 2025

Bragar Eagel & Squire, P.C. Is Investigating Organon, Aldeyra, Landstar, and ICU Medical ... - Eagle-Tribune

May 14, 2025
pulisher
May 14, 2025

Bragar Eagel & Squire, P.C. Is Investigating Organon, - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Aldeyra Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 13, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra - Bluefield Daily Telegraph

May 13, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Acquires Shares of 10,457 Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 13, 2025
pulisher
May 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc.ALDX - PR Newswire

May 12, 2025
pulisher
May 11, 2025

SHAREHOLDER ALERT: Potential Recovery for Aldeyra Therapeutics, Inc. (ALDX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

May 11, 2025
pulisher
May 11, 2025

Barclays PLC Has $376,000 Stake in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 11, 2025
pulisher
May 08, 2025

(ALDX) Trading Advice - news.stocktradersdaily.com

May 08, 2025
pulisher
May 08, 2025

Bragar Eagel & Squire, P.C. Is Investigating RobinHood, - GlobeNewswire

May 08, 2025
pulisher
May 07, 2025

Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical ... - Eagle-Tribune

May 07, 2025
pulisher
May 07, 2025

Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm - TradingView

May 07, 2025
pulisher
May 07, 2025

Aldeyra Therapeutics Drops To US$2.10, Yet Insiders May Have Sold Too Early - simplywall.st

May 07, 2025
pulisher
May 07, 2025

ALDX SECURITIES UPDATE: Aldeyra Therapeutics Investors with - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Aldeyra makes third run at FDA approval for dry eye drug - The Pharma Letter

May 07, 2025
pulisher
May 06, 2025

Aldeyra Plans To File Reproxalap Again With New Dry Eye Symptom Data - insights.citeline.com

May 06, 2025
pulisher
May 06, 2025

Aldeyra DED phase III hits but reproxalap field goal fumbled - BioWorld MedTech

May 06, 2025
pulisher
May 06, 2025

Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After - GlobeNewswire

May 06, 2025
pulisher
May 06, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Aldeyra Therapeutics, Inc.(ALDX) Investors of a Class Action Lawsuit and Upcoming Deadline - Barchart.com

May 06, 2025
pulisher
May 06, 2025

SHAREHOLDER ALERT: Potential Recovery for Aldeyra Therapeutics, Inc. (ALDX) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

May 06, 2025
pulisher
May 06, 2025

Aldeyra plots third FDA filing for dry eye disease drug after latest Phase 3 data - Endpoints News

May 06, 2025
pulisher
May 06, 2025

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Ey - GuruFocus

May 06, 2025
pulisher
May 05, 2025

Aldeyra (ALDX) Hits Primary Endpoint in Dry Eye Treatment Trial - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Aldeyra (ALDX) Hits Primary Endpoint in Dry Eye Treatment Trial | ALDX Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Breakthrough in Dry Eye Treatment: Aldeyra's Reproxalap Achieves Significant Phase 3 Results, FDA Filing Next - Stock Titan

May 05, 2025
pulisher
May 05, 2025

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Topline Results from Phase 3 Dry Eye Disease Clinical Trials of Reproxalap - Business Wire

May 05, 2025
pulisher
May 05, 2025

ALDX SECURITIES ALERT: Lose Money on Aldeyra Therapeutics, - GlobeNewswire

May 05, 2025
pulisher
May 05, 2025

Allergic Conjunctivitis Pipeline 2025: FDA Approvals, Therapies, Clinical Trials, and Latest Developments Unveiled by DelveInsight | Bausch & Lomb Inc, Aldeyra Therapeutics, Vanda Pharma, OKYO Pharma - Barchart.com

May 05, 2025
pulisher
May 05, 2025

Invesco Ltd. Cuts Holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 05, 2025
pulisher
May 03, 2025

ALDX INQUIRY NOTICE: Aldeyra Therapeutics (NASDAQ:ALDX) - GlobeNewswire

May 03, 2025
pulisher
May 03, 2025

ALDX INQUIRY NOTICE: Aldeyra Therapeutics (NASDAQ:ALDX) Investors may have been affected by Securities Violations -- Contact BFA Law - GlobeNewswire Inc.

May 03, 2025
pulisher
May 02, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 02, 2025
pulisher
May 02, 2025

Renaissance Technologies LLC Purchases 59,700 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 02, 2025
pulisher
May 01, 2025

ALDX INVESTIGATION NOTICE: Aldeyra Therapeutics, Inc. Investors are Notified of the Ongoing Securities Investigation - TradingView

May 01, 2025
pulisher
May 01, 2025

Aldeyra Therapeutics Inc (ALDX) Stock: Navigating a Year of Stock Volatility - investchronicle.com

May 01, 2025
pulisher
May 01, 2025

It makes sense and dollars to buy Aldeyra Therapeutics Inc (ALDX) stock - Sete News

May 01, 2025
pulisher
Apr 30, 2025

Neuropathic Ocular Pain Pipeline 2025: In-depth Clinical - openPR.com

Apr 30, 2025
pulisher
Apr 30, 2025

Investing in Aldeyra Therapeutics Inc (ALDX) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - uspostnews.com

Apr 30, 2025
$1.0846
price down icon 1.76%
$29.97
price down icon 0.70%
$577.79
price up icon 0.89%
$306.27
price up icon 0.67%
$4.47
price down icon 2.22%
$489.50
price down icon 0.11%
Capitalizzazione:     |  Volume (24 ore):